Patent ID: 11865167
Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The method of claim 1, wherein the anti-EGFRvIII binding domain comprises:
(1) the amino acid sequence of SEQ ID NO:68, SEQ ID NO:50, or SEQ ID NO:80;
(2) an amino acid sequence with at least 95% sequence identity to SEQ ID NO:68, SEQ ID NO:50, or SEQ ID NO:80; or
(3) an amino acid sequence having at least one, two or three modifications but not more than 10 modifications of the amino acid sequence of SEQ ID NO:68, SEQ ID NO:50, or SEQ ID NO:80.